全血凝血酶生成受损与急性失代偿期肝硬化操作相关出血相关
前瞻性研究纳入231例肝硬化患者(80例代偿期、70例稳定失代偿期、81例急性失代偿期),中位随访414天,发现11例急性失代偿期患者发生操作相关出血,其全血凝血酶生成的内源性凝血酶潜力低于无出血者,且全血凝血酶生成可识别个体水平的大出血,但全血和乏血小板血浆凝血酶生成均不能预测血栓形成。
要点
- 急性失代偿期肝硬化患者中,全血凝血酶生成的内源性凝血酶潜力对操作相关出血的AUC为0.854(95% CI 0.732-0.976)。
- 所有发生大出血的患者术前全血凝血酶生成的内源性凝血酶潜力均低于350 nmol/L∗min。
- 全血和乏血小板血浆凝血酶生成均不能预测血栓形成,主要为门静脉血栓(n=15)。
核心结论
- 在代偿期肝硬化中,全血和乏血小板血浆凝血酶生成不能改善风险分层。
- 在失代偿期肝硬化中,全血凝血酶生成可能是评估操作相关出血风险的有前景工具。
研究设计与样本
- 前瞻性研究,纳入231例肝硬化患者:80例代偿期、70例稳定失代偿期、81例急性失代偿期。
- 在招募时进行全血和乏血小板血浆凝血酶生成检测,并前瞻性随访出血/血栓形成、肝失代偿和肝相关死亡。
- 中位随访414天(范围:77-668天)。
主要发现
- 11例患者发生操作相关出血,均为急性失代偿期肝硬化。
- 出血患者较非出血患者全血和乏血小板血浆凝血酶生成改变更明显(内源性凝血酶潜力和峰值更低)。
- 仅全血凝血酶生成可在个体患者水平识别发生大出血者(所有患者术前内源性凝血酶潜力<350 nmol/L∗min)。
- 在急性失代偿期肝硬化中,全血凝血酶生成内源性凝血酶潜力预测出血的AUC为0.854(95% CI 0.732-0.976),高于乏血小板血浆凝血酶生成内源性凝血酶潜力的AUC 0.676(95% CI 0.524-0.809)。
- 全血和乏血小板血浆凝血酶生成均不能预测血栓形成,主要为门静脉血栓(n=15)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The clinical utility of thrombomodulin-modified thrombin generation (TM-TG) in cirrhosis is uncertain. We conducted a prospective study to evaluate the prognostic value of TM-TG in cirrhosis. METHODS: Patients were recruited during outpatient clinics (compensated and stable decompensated cirrhosis) or if admitted to our inpatient service (acutely decompensated cirrhosis). We performed whole blood (WB) and platelet-poor plasma (PPP) TM-TG at recruitment. All patients were prospectively followed-up for bleeding/thrombosis, hepatic decompensation, and liver-related death. RESULTS: We included 231 patients: 80 with compensated, 70 with stable decompensated, and 81 with acutely decompensated cirrhosis. Median follow-up was 414 days (range: 77-668). Eleven patients, all with acutely decompensated cirrhosis, experienced procedure-related bleeding. Both WB-TG and PPP-TG were more altered in bleeding vs. non-bleeding individuals (lower endogenous thrombin potential [ETP] and peak-height). However, only WB-TG could identify - at the individual patient level - those experiencing major bleeding (all having pre-procedural ETP <350 nmol/L∗min). In acutely decompensated cirrhosis, the AUC of WB-TG ETP for bleeding was 0.854 (95% CI 0.732-0.976), which was higher than that of PPP-TG ETP (0.676; 95% CI 0.524-0.809). Neither WB-TG nor PPP-TG could predict development of thrombosis, mostly portal vein thrombosis (n = 15). In compensated cirrhosis, WB-TG and PPP-TG were comparable between patients who experienced decompensation and those who did not. In decompensated cirrhosis, WB-TG and PPP-TG were more significantly altered in patients experiencing further decompensation/ACLF/liver-related death. A higher WB-TG ETP was linked to a lower risk of progression independently of MELD, Child-Pugh, and C-reactive protein (hazard ratio 0.4, 95% CI 0.21-0.79, p <0.01). CONCLUSIONS: In compensated cirrhosis, WB-TG and PPP-TG do not improve risk stratification. In decompensated cirrhosis, WB-TG may be a promising tool for estimating procedure-related bleeding risk. IMPACT AND IMPLICATIONS: Thrombomodulin-modified thrombin generation (TM-TG) in cirrhosis is a well-established research tool to assess the complex coagulopathy of cirrhosis; however, its clinical utility is uncertain. In acutely decompensated cirrhosis, a TM-modified whole blood (WB)-TG ETP <350 nmol/L∗min predicted major bleeding after invasive procedures, whereas platelet-poor plasma TG indicated a hypo-coagulable state in bleeding patients but could not identify those at risk. Neither WB-TG nor platelet-poor plasma-TG could predict development of portal vein thrombosis, which was predicted by cirrhosis and portal hypertension severity. In decompensated cirrhosis, a better WB-TG capacity was associated with a lower risk of further decompensation, acute-on-chronic liver failure, and liver-related death independently of MELD score/Child-Pugh stage and C-reactive protein.
引用
- Zanetto A, Campello E, Bulato C, et al. Impaired whole blood thrombin generation is associated with procedure-related bleeding in acutely decompensated cirrhosis. J Hepatol. 2024. PMID: 39672204. doi:10.1016/j.jhep.2024.12.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。